---
$id: https://graph.org.ai/products/commodity/51313109
$type: Product
source: UNSPSC
code: "51313109"
title: "Buclizine dihydrochloride"
class: "51313100"
classTitle: "Antihistamine or H1 blocker piperazines"
family: "51310000"
familyTitle: "Antihistamines or H1 blockers"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Buclizine dihydrochloride

**UNSPSC Code**: 51313109
**Class**: [Antihistamine or H1 blocker piperazines](Antihistamine or H1 blocker piperazines.mdx)
**Family**: [Antihistamines or H1 blockers](../Antihistamines or H1 blockers.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a histamine-1 receptor antagonist with the molecular formula C28H33ClN2.2ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 58FQD093NU, chemically known as piperazine, 1-((4-chlorophenyl)phenylmethyl)-4-((4-(1,1-dimethylethyl)phenyl)methyl)-, dihydrochloride, but more generally known as buclizine dihydrochloride, which bears US NIH Compound Identifier 6729. European Medicines Agency schedules buclizine dihydrochloride or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05947MIG. Most nations, for tariff purposes, schedule buclizine dihydrochloride under HS 29335995. SMILES: CC(C)(C)C1CCC(CC1)CN2CCN(CC2)C(C3CCCCC3)C4CCC(CC4)CL.CL.CL.

